Premium
Letter: infliximab de‐escalation based on trough levels in patients with inflammatory bowel disease – authors' reply
Author(s) -
Chaparro M.,
Gisbert J. P.
Publication year - 2015
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13368
Subject(s) - infliximab , medicine , trough (economics) , de escalation , inflammatory bowel disease , gastroenterology , therapeutic index , trough level , disease , tumor necrosis factor alpha , trough concentration , pharmacology , pharmacokinetics , drug , transplantation , economics , macroeconomics , tacrolimus